The Effect of Progressive Relaxation Exercises on Sleep Quality

NCT ID: NCT05647148

Last Updated: 2022-12-12

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Clinical Phase

NA

Total Enrollment

60 participants

Study Classification

INTERVENTIONAL

Study Start Date

2022-05-09

Study Completion Date

2022-12-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This study; In order to investigate the effect of progressive relaxation exercises on sleep quality, serotonin and melatonin levels in cardiac patients with sleep problems, a pretest/posttest experimental design study will be conducted with a control group.

The data of this study will be collected between May 2022 and December 2022. The research will be carried out with a total of 60 (experimental group=30, control group=30) patients treated for heart failure, myocardial infarction and angina pectoris in the cardiology clinic of a university hospital.

The data of the study will be collected using the Richard's Campbell Sleep Scale and the Commercial ELISA kit.

Progressive relaxation exercises will be applied to the patients included in the experimental group for 3 consecutive days.

Before relaxation exercises, urine melatonin, serotonin level \[5-hydroxyindolacetic acid (5-HIAA) and 6-sulphatoxymelatonin(6-HMS)\] measurement and sleep quality will be measured according to the kit procedure.

In the analysis of the data, significance p \<0.05 will be accepted. Institutional permission, ethics committee approval, and written consent from the participants were obtained before the study.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

The data of this study will be collected between May 2022 and December 2022. The research will be carried out with a total of 60 (experimental group=30, control group=30) patients treated for heart failure, myocardial infarction and angina pectoris in the cardiology clinic of a university hospital.

The study was planned as a randomized controlled experiment. Patients meeting the research criteria will be randomly assigned to 30 experimental-30 control groups by randomization method.

Information Form, Richard's Campbell Sleep Scale and commercial ELISA kit will be used as data collection tools in the research.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Sleep Disturbance Nursing Care

Keywords

Explore important study keywords that can help with search, categorization, and topic discovery.

sleep quality progressive relaxation Exercises melatonin serotonin

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

randomized controlled study
Primary Study Purpose

SUPPORTIVE_CARE

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

intervention group

progressive relaxiation exercises Will do sixty minutes of progressive relaxation exercise for three consecutive days

Group Type EXPERIMENTAL

Progressive Relaxation Exercises

Intervention Type BEHAVIORAL

In the first part of this audio material, which consists of three parts; The definition of deep relaxation, its purpose and points to be considered during exercise are included.

The second part, consisting of an average of thirty minutes, includes the explanation of relaxation exercises with verbal commands accompanied by the sound of the stream.

In the last part, there is only relaxation music without any commands.

Control group:

no intervention

Group Type NO_INTERVENTION

No interventions assigned to this group

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Progressive Relaxation Exercises

In the first part of this audio material, which consists of three parts; The definition of deep relaxation, its purpose and points to be considered during exercise are included.

The second part, consisting of an average of thirty minutes, includes the explanation of relaxation exercises with verbal commands accompanied by the sound of the stream.

In the last part, there is only relaxation music without any commands.

Intervention Type BEHAVIORAL

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* older than 18 years of age,
* who reported sleep problems
* scored 25 or less on the Richard's Campbell Sleep Scale,
* were scheduled to be hospitalized for at least 4 days,
* had no pain, were able to give urine samples,
* were lying in a single or double room,
* had serotonin-containing or decreased serotonin secretion.
* do not take any medication that provides medical treatment,
* can do PGE,
* do not have a hearing problem or a communication disability will be admitted.

Exclusion Criteria

* who were discharged early,
* had an unexpected change in their condition,
* started to experience pain,
* could not adapt to the working principles,
* gave up volunteering will be excluded from the study.
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Ataturk University

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Tunc ELIS

LECTURER

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Tunç ELİŞ

Role: PRINCIPAL_INVESTIGATOR

Kafkas Universıty/Turkey

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Atatürk University

Erzurum, , Turkey (Türkiye)

Site Status RECRUITING

Ataturk Üniversity

Erzurum, , Turkey (Türkiye)

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

Turkey (Türkiye)

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Tunç ELİŞ

Role: CONTACT

Phone: 04742426840

Email: [email protected]

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

reva balcı akpınar, prof.

Role: primary

reva balcı akpınar, prof

Role: primary

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

AU-TELIS

Identifier Type: -

Identifier Source: org_study_id